Fanqi Bai

Reduced natural killer (NK) function associated with high-risk myelodysplastic syndrome (MDS) and reduced expression of activating NK receptors

Pearlie K. Epling‐Burnette, Fanqi Bai, Jeffrey S. Painter et al. · Blood · 2007 · 225 citations · Full text

Life Sciences, Hematology, Immunology +17

Cooperative Regulation of Mcl-1 by Janus Kinase/STAT and Phosphatidylinositol 3-Kinase Contribute to Granulocyte-Macrophage Colony-Stimulating Factor-Delayed Apoptosis in Human Neutrophils

Pearlie K. Epling‐Burnette, Bin Zhong, Fanqi Bai et al. · The Journal of Immunology · 2001 · 179 citations

Life Sciences, Cell Biology, Immunology +17

A phase I trial combining decitabine/dendritic cell vaccine targeting MAGE-A1, MAGE-A3 and NY-ESO-1 for children with relapsed or therapy-refractory neuroblastoma and sarcoma

Deepa Kolaseri Krishnadas, Suzanne Shusterman, Fanqi Bai et al. · Cancer Immunology Immunotherapy · 2015 · 173 citations · Full text

Medicine, Immunology, Oncology +14

Prevalence and clinical association of clonal T-cell expansions in Myelodysplastic Syndrome

Pearlie K. Epling‐Burnette, Jeffrey S. Painter, Dana E. Rollison et al. · Leukemia · 2007 · 129 citations

Medicine, Hematology, Immunology +13

Inhibition of Bcr–Abl kinase activity by PD180970 blocks constitutive activation of Stat5 and growth of CML cells

Mei Huang, Jay F. Dorsey, PK Epling-Burnette et al. · Oncogene · 2002 · 121 citations · Full text

Life Sciences, Cell Biology, Molecular Biology +5